Fortress Biotech, Inc. (FBIO) › Capital ExpendituresFortress Biotech, Inc. (FBIO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $02012: $54.0K2013: $40.0K2014: $02015: $283.0K2016: $6.37M2017: $648.0K2018: $7.08M2019: $2.35M2020: $1.93M2021: $4.57M2022: $2.71M2023: $63.0K2024: $0$02011Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$0-100.0%2023$63.0K-97.7%2022$2.71M-40.5%2021$4.57M+137.1%2020$1.93M-17.9%2019$2.35M-66.9%2018$7.08M+992.9%2017$648.0K-89.8%2016$6.37M+2150.9%2015$283.0K—2014$0-100.0%2013$40.0K-25.9%2012$54.0K—2011$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share